NASDAQ:APTX - Nasdaq - US03836N1037 - Common Stock - Currency: USD
Gainers
Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.
It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!
AMC Entertainment (AMC) stock is in the news after the movie theater company announced it will launch its own line of popcorn at Walmart.
AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
Aptinyx (APTX) lost Tuesday after a setback for its Phase 2 trial for NYX-458 in cognitive impairment linked to Parkinson’s disease and dementia with Lewy bodies. Read the full story here.